Neuren Pharmaceuticals Limited (ASX:NEU)
Australia · Delayed Price · Currency is AUD 20.72
+0.05 (0.24%)
Sep 15, 2026, 4:10 PM AEST
Neuren Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Neuren Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $26.03. The average 1-year stock price forecast is 25.63% higher than the current stock price, while the lowest is $24.50 (+18.24%) and the highest is $28.90 (+39.48%).
Price Target: $26.03 (+25.63%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Neuren Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Ord Minnett No rating | Ord Minnett | Buy Maintains $27.60 | Buy | Maintains | $27.60 | +33.20% | Sep 4, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $24.76 | Buy | Maintains | $24.76 | +19.50% | Aug 30, 2026 |
| Jefferies | Jefferies | Buy Maintains $29.40 → $28.90 | Buy | Maintains | $29.40 → $28.90 | +39.48% | Aug 27, 2026 |
| Bell Potter | Bell Potter | Buy Maintains $25.50 | Buy | Maintains | $25.50 | +23.07% | Aug 27, 2026 |
Unknown Analyst Macquarie No rating | Macquarie | Buy Maintains $23.00 → $24.50 | Buy | Maintains | $23.00 → $24.50 | +18.24% | Aug 27, 2026 |
Financial Forecast
Revenue This Year
115.94M
from 64.65M
Increased by 79.33%
Revenue Next Year
172.60M
from 115.94M
Increased by 48.87%
EPS This Year
0.41
from 0.23
Increased by 74.10%
EPS Next Year
0.60
from 0.41
Increased by 47.29%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.